Fat metabolism in diabetes

Joslin's Diabetes Mellitus: Fourteenth Edition

Volumn , Issue , 2011, Pages 265-273

  Basu, Ananda ^a   Jensen, Michael D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84970983939     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (140)

1. Hellerstein MK, Christiansen M, Kaempfer S, et al. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. . Clin Invest 1991;87: 1841-1852.
2. Mayes PA. Lipid transport and storage. In: Murray RK, Granner, DK, Mayes, PA, Rodwell VW. Harper's biochemistry, 24th ed. Norwalk, CT: Appleton & Lange, 1996:254-270.
3. Romanski SA, Nelson RM, Jensen MD. Meal fatty acid uptake in adipose tissue: gender effects in nonobese humans. Am J Physiol Endocrinol Metab 2000;279:E455-E462.
4. Roust LR, Jensen MD. Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes 1993;42:1567-1573.
5. Jensen MD. Assessment of free fatty acid metabolism. In: Draznin B, Rizza R, eds. Clinical research in diabetes and obesity: methods, assessment and metabolic regulation. Totowa, NJ: Humana Press, 1997:125-136.
6. Eckel RH. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. . Engl J Med 1989;320:1060-1068.
7. Coppack SW, Jensen MD, Miles JM. In vivo regulation of lipolysis in humans. . Lipid Res 1994;35:177-193.
8. Farese RV Jr, Yost TJ, Eckel RH. Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism 1991;40:214-216.
9. Jensen MD, Haymond MW, Rizza RA, et al. Influence of body fat distribution on free fatty acid metabolism in obesity. . Clin Invest 1989;83:1168-1173.
10. Kanaley JA, Mottram CD, Scanlon PD, et al. Fatty acid kinetic responses to running above or below lactate threshold. . Appl Physiol 1995;79:439-447.
11. Groop LC, Bonadonna RC, DelPrato S, et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. . Clin Invest 1989;84:205-213.
12. Guo Z, Jensen MD. Intramuscular fatty acid metabolism evaluated with stable isotopic tracers. . Appl Physiol 1998;84:1674-1679.
13. Groop LC, Bonadonna RC, Shank M, et al. Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. . Clin Invest 1991;87:83-89.
14. Havel RJ, Kane JP, Balasse EO, et al. Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. . Clin Invest 1970;49: 2017-2035.
15. Basso LV, Havel RJ. Hepatic metabolism of free fatty acids in normal and diabetic dogs. . Clin Invest 1970;49:537-547.
16. Jensen MD, Caruso M, Heiling V, et al. Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 1989;38:1595-1601.
17. Wahrenberg H, Lonnqvist F, Arner P: Mechanisms underlying regional differences in lipolysis in human adipose tissue. . Clin Invest 1989;84: 458-467.
18. Burns TW, Langley PE, Terry BE, et al. The role of free fatty acids in the regulation of lipolysis by human adipose tissue cells. Metabolism 1978;27:1755-1762.
19. Leibel RL, Forse RA, Hirsch J. Effects of rapid glucose infusion on in vivo and in vitro free fatty acid re-esterification by adipose tissue of fasted obese subjects. Int J Obes 1989;13:661-671.
20. Coppack SW, Frayn KN, Humphreys SM, et al. Effects of insulin on human adipose tissue metabolism in vivo. Clin Sci 1989;77:663-670.
21. Divertie GD, Jensen MD, Miles JM. Stimulation of lipolysis in humans by physiological hypercortisolemia. Diabetes 1991;40:1228-1232.
22. Horber FF, Marsh HM, Haymond MW. Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes 1991;40:141-149.
23. Shamoon H, Hendler R, Sherwin RS. Altered responsiveness to cortisol, epinephrine, and glucagon in insulin-infused juvenile-onset diabetics. A mechanism for diabetic instability. Diabetes 1980;29:284-291.
24. Birkenhager JC, Timmermans HA, Lamberts SW. Depressed plasma FFA turnover rate in Cushing's syndrome. . Clin Endocrinol Metab 1976;42:28-32.
25. Goodman HM, Grichting G. Growth hormone and lipolysis: a reevaluation. Endocrinology 1983;113:1697-1702.
26. Boyle PJ, Avogaro A, Smith L, et al. Role of GH in regulating nocturnal rates of lipolysis and plasma mevalonate levels in normal and diabetic humans. Am J Physiol 1992;263:E168-E172.
27. Cersosimo E, Danou F, Persson M, et al. Effects of pulsatile delivery of basal growth hormone on lipolysis in humans. Am J Physiol 1996;271:E123-E126.
28. Saunders J, Hall SE, Sonksen PH. Glucose and free fatty acid turnover in thyrotoxicosis and hypothyroidism, before and after treatment. Clin Endocrinol 1980;13:33-44.
29. Starnes HF Jr, Warren RS, Jeevanandam M, et al. Tumor necrosis factor and the acute metabolic response to tissue injury in man. . Clin Invest 1988;82: 1321-1325.
30. Axelrod L. Insulin, prostaglandins, and the pathogenesis of hypertension. Diabetes 1991;40:1223-1227.
31. Miles JM, Ellman MG, McLean KL, et al. Validation of a new method for determination of free fatty acid turnover. Am J Physiol 1987;252:E431-E438.
32. Jensen MD, Rogers PJ, Ellman MG, et al. Choice of infusion-sampling mode for tracer studies of free fatty acid metabolism. Am J Physiol 1988;254:E562-E565.
33. Butler PC, Home PD. The measurement of metabolite exchange across muscle beds. Baillieres Clin Endocrinol Metab 1987;1:863-878.
34. Frayn KN, Coppack SW, Humphreys SM, et al. Metabolic characteristics of human adipose tissue in vivo. Clin Sci 1989;76:509-516.
35. Meek SE, Nair KS, Jensen MD: Insulin regulation of regional free fatty acid metabolism. Diabetes 1999;48:10-14.
36. Hagenfeldt L, Wahren J, Pernow B, et al. Uptake of individual free fatty acids by skeletal muscle and liver in man. . Clin Invest 1972;51:2324-2330.
37. Spitzer JJ. Application of tracers in studying free fatty acid metabolism of various organs in vivo. Fed Proc 1975;34:2242-2245.
38. Guo Z, Nielsen S, Burguera B, et al. Free fatty acid turnover measured using ultralow doses of [U-13C] palmitate. . Lipid Res 1997;38:1888-1895.
39. Klein S, Coyle EF, Wolfe RR. Fat metabolism during low-intensity exercise in endurance-trained and untrained men. Am J Physiol 1994;267:E934-E940.
40. Romijn JA, Klein S, Coyle EF, et al. Strenuous endurance training increases lipolysis and triglyceride-fatty acid cycling at rest. . Appl Physiol 1993;75: 108-113.
41. Wolfe RR, Klein S, Carraro F, et al. Role of triglyceride-fatty acid cycle in controlling fat metabolism in humans during and after exercise. Am J Physiol 1990;258:E382-E389.
42. Miyoshi H, Shulman GI, Peters EJ, et al. Hormonal control of substrate cycling in humans. . Clin Invest 1988;81:1545-1555.
43. Wolfe RR, Herndon DN, Jahoor F, et al. Effect of severe burn injury on substrate cycling by glucose and fatty acids. . Engl J Med 1987;317:403-408.
44. Boden G, Chen X, Desantis RA, et al. Effects of insulin on fatty acid reesterification in healthy subjects. Diabetes 1993;42:1588-1593.
45. Kurpad A, Khan K, Calder AG, et al. Effect of noradrenaline on glycerol turnover and lipolysis in the whole body and subcutaneous adipose tissue in humans in vivo. Clin Sci 1994;86:177-184.
46. Martin ML, Jensen MD. Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest 1991;88:609-613.
47. Arner P, Kriegholm E, Engfeldt P. In situ studies of catecholamine-induced lipolysis in human adipose tissue using microdialysis. . Pharmacol Exp Ther 1990;254:284-288.
48. Arner P, Krieghold E, Engfeldt P, et al. Adrenergic regulation of lipolysis in situ at rest and during exercise. . Clin Invest 1990;85:893-898.
49. Arner P, Bolinder J, Eliasson A, et al. Microdialysis of adipose tissue and blood for in vivo lipolysis studies. Am J Physiol 1988;255:E737-E742.
50. Jansson PA, Smith U, Lonnroth P. Interstitial glycerol concentration measured by microdialysis in two subcutaneous regions in humans. Am J Physiol 1990;258:E918-E922.
51. Jansson PA, Smith U, Lonnroth P. Evidence for lactate production by human adipose tissue in vivo. Diabetologia 1990;33:253-256.
52. Jensen MD, Kanaley JA, Reed JE, et al. Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am J Clin Nutr 1995;61:274-278.
53. Jensen MD, Kanaley JA, Roust LR, et al. Assessment of body composition with use of dual-energy x-ray absorptiometry: evaluation and comparison with other methods. Mayo Clin Proc 1993;68:867-873.
54. Canner PL, Berge KG, Wenger NK, et al: Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. . Am Coll Cardiol 1986;8: 1245-1255.
55. Fulcher GR, Walker M, Catalano C, et al. Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes 1992;4:1400-1408.
56. Vaag A, Skott P, Damsbo P, et al. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. . Clin Invest 1991;88: 1282-1290.
57. Randle PJ, Priestman DA, Mistry S, et al. Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia 1994;37[Suppl 2]:S155-S161.
58. Bailey JW, Jensen MD, Miles JM. Effects of intravenous methyl palmoxirate on the turnover and oxidation of fatty acids in conscious dogs. Metabolism 1991;40:428-431.
59. Bensadoun A. Lipoprotein lipase. Annu Rev Nutr 1990;11:217-237.
60. Randle PJ, Hales CN, Garland PB, et al. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:7285-7289.
61. Boden G, Chen X, Ruiz J, et al. Mechanisms of fatty acid-induced inhibition of glucose uptake. . Clin Invest 1994;93:2438-2446.
62. Boden G, Jadali F, White J, et al. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. . Clin Invest 1991;88:960-966.
63. Kelley DE, Mokan M, Simoneau JA, et al. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. . Clin Invest 1993; 92:91-98.
64. Dresner A, Laurent D, Marcucci M, et al. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. . Clin Invest 1999;103:253-259.
65. Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans. . Clin Invest 1996;97:2859-2865.
66. Saloranta C, Koivisto V, Widen E, et al. Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am J Physiol 1993;264:E599-E605.
67. Baron AD, Brechtel G, Edelman SV: Effects of free fatty acids and ketone bodies on in vivo non-insulin-mediated glucose utilization and production in humans. Metabolism 1989;38:1056-1061.
68. Sidossis LS, Mittendorfer B, Chinkes D, et al. Effect of hyperglycemiahyperinsulinemia on whole body and regional fatty acid metabolism. Am J Physiol 1999;276:E427-E434.
69. Sidossis LS, Wolfe RR. Glucose and insulin-induced inhibition of fatty acid oxidation: the glucose-fatty acid cycle reversed. Am J Physiol 1996;270:E733-E738.
70. Lea MA, Weber G. Role of enzymes in homeostasis. Inhibition of the activity of glycolytic enzymes by free fatty acids. . Biol Chem 1968;243:1096-1102.
71. Johnson JH, Newgard CB, Milburn JL, et al. The high Km glucose transporter of islets of Langerhans is functionally similar to the low affinity transporter of liver and has an identical primary sequence. . Biol Chem 1990;265:6548-6551.
72. Mueckler M. Facilitative glucose transporters. Eur J Biochem 1994;219: 713-725.
73. Gould GW, Holman GD. The glucose transporter family: structure, function and tissue-specific expression. Biochem J 1993;295:329-341.
74. Struck E, Ashmore J, Wieland O. Effects of glucagon and long chain fatty acids on glucose production by isolated perfused rat liver. Adv Enzyme Regul 1966;4:219-224.
75. Herrera MG, Kamm D, Ruderman NB, et al. Non-hormonal factors in the control of gluconeogenesis. Adv Enzyme Regul 1966;4:225-235.
76. Ferrannini E, Barrett EJ, Bevilacqua S, et al. Effect of fatty acids on glucose production and utilization in man. . Clin Invest 1983;72:1737-1747.
77. Boden G, Jadali F. Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes 1991;40:686-692.
78. Clore JN, Glickman PS, Nestler JE, et al. In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans. Am J Physiol 1991;261:E425-E429.
79. Chen X, Iqbal N, Boden G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. . Clin Invest 1999;103:365-372.
80. Bergman RN. New concepts in extracellular signaling for insulin action: the single gateway hypothesis. Recent Prog Horm Res 1997;52:359-385.
81. Rebrin K, Steil GM, Mittelman SD, et al. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. . Clin Invest 1996;98:741-749.
82. Lewis GF, Vranic M, Giacca A. Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans. Am J Physiol 1998;275:E177-E186.
83. Lewis GF, Zinman B, Groenewoud Y, et al. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 1996;45:454-462.
84. Groop LC, Saloranta C, Shank M, et al. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. . Clin Endocrinol Metab 1991;72:96-107.
85. Saloranta C, Franssila-Kallunki A, Ekstrand A, et al. Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulindependent) diabetes mellitus. Diabetologia 1991;34:409-415.
86. Paolisso G, Tataranni PA, Foley JE, et al. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 1995;38:1213-1217.
87. Boden G, Chen X, Rosner J, et al. Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 1995;44:1239-1242.
88. Paolisso G, Gambardella A, Amato L, et al. Opposite effects of short-and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 1995;38:1295-1299.
89. Carpentier A, Mittelman SD, Lamarche B, et al. Acute enhancement of insulin secretion by FFAin humans is lost with prolonged FFAelevation. Am J Physiol 1999;276:E1055-E1066.
90. Mason TM, Goh T, Tchipashvili V, et al. Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes 1999;48:524-530.
91. Lee Y, Hirose H, Ohneda M, et al. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A 1994;91:10878-10882.
92. Zhou YP, Grill VE. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. . Clin Invest 1994;93:870-876.
93. Bollheimer LC, Skelly RH, Chester MW, et al. Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. . Clin Invest 1998;101:1094-1101.
94. Brun T, Assimacopoulos-Jeannet F, Corkey BE, et al. Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1. Diabetes 1997;46:393-400.
95. Gremlich S, Bonny C, Waeber G, et al. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. . Biol Chem 1997;272:30261-30269.
96. Larsson O, Deeney JT, Branstrom R, et al. Activation of the ATP-sensitive K+ channel by long chain acyl-CoA. A role in modulation of pancreatic beta-cell glucose sensitivity. . Biol Chem 1996;271:10623-10626.
97. Duckworth WC, Bennett RG, Hamel FG: Insulin degradation: progress and potential. Endocr Rev 1998;19:608-624.
98. Duckworth WC. Insulin degradation: mechanisms, products, and significance. Endocr Rev 1988;9:319-345.
99. Hennes MM, Shrago E, Kissebah AH. Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics. Int J Obes 1990;14: 831-841.
100. Svedberg J, Bjorntorp P, Smith U, et al. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 1990; 39:570-574.
101. Skowronski R, Hollenbeck CB, Varasteh BB, et al. Regulation of non-esterified fatty acid and glycerol concentration by insulin in normal individuals and patients with type 2 diabetes. Diabet Med 1991;8:330-333.
102. Reaven GM, Hollenbeck C, Jeng CY, et al. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988;37:1020-1024.
103. Nurjhan N, Consoli A, Gerich J. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. . Clin Invest 1992;89:169-175.
104. Basu A, Basu R, Shah P, et al. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes 2000;49:272-283.
105. Basu A, Basu R, Shah P, et al. Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol 2001;280:E1000-E1006.
106. Despres JP, Allard C, Tremblay A, et al. Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism 1985;34:967-973.
107. Reaven GM: Syndrome X: 6 years later. . Intern Med 1994;736[Suppl]:13-22.
108. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease. Am J Clin Nutr 1956;4:20-34.
109. Anderson AJ, Sobocinski KA, Freedman DS, et al. Body fat distribution, plasma lipids, and lipoproteins. Arteriosclerosis 1988;8:88-94.
110. Thompson CJ, Ryu JE, Craven TE, et al. Central adipose distribution is related to coronary atherosclerosis. Arterioscler Thromb 1991;11:327-333.
111. Bonora E, Prato S, Bonadonna RC, et al. Total body fat content and fat topography are associated differently with in vivo glucose metabolism in nonobese and obese nondiabetic women. Diabetes 1992;41:1151-1159.
112. Pouliot MC, Despres JP, Nadeau A, et al. Visceral obesity in men. Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992;41:826-834.
113. Seidell JC, Bjorntorp P, Sjostrom L, et al. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990;39:897-901.
114. Rice T, Despres JP, Daw EW, et al. Familial resemblance for abdominal visceral fat: the HERITAGE Family Study. Int J Obes Relat Metab Disord 1997;21: 1024-1031.
115. Perusse L, Despres JP, Lemieux S, et al. Familial aggregation of abdominal visceral fat level: results from the Quebec family study. Metabolism 1996;45: 378-382.
116. Carey VJ, Walters EE, Colditz GA, et al. Body fat distribution and risk of noninsulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol 1997;145:614-619.
117. Rexrode KM, Carey VJ, Hennekens CH, et al. Abdominal adiposity and coronary heart disease in women. JAMA 1998;280:1843-1848.
118. Sparrow D, Borkan GA, Gerzof SG, et al. Relationship of fat distribution to glucose tolerance. Results of computed tomography in male participants of the Normative Aging Study. Diabetes 1986;35:411-415.
119. Fujioka S, Matsuzawa Y, Tokunaga K, et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987;36:54-59.
120. Despres JP, Moorjani S, Tremblay A, et al. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women. Clin Invest Med 1989;12:374-380.
121. Abate N, Garg A, Peshock RM, et al. Relationships of generalized and regional adiposity to insulin sensitivity in men. . Clin Invest 1995;96: 88-98.
122. Peiris AN, Mueller RA, Smith GA, et al. Splanchnic insulin metabolism in obesity. Influence of body fat distribution. . Clin Invest 1986;78:1648-1657.
123. Hennes MM, Dua A, Kissebah AH. Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 1997;46:57-62.
124. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991;14:1132-1143.
125. Guo Z, Hensrud DD, Johnson CM, et al. Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes 1999;48:1586-1592.
126. Barzilai N, She L, Liu BQ, et al. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 1999;48:94-98.
127. Barzilai N, Banerjee S, Hawkins M, et al. Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. . Clin Invest 1998;101:1353-1361.
128. Barzilai N, She L, Liu L, et al. Decreased visceral adiposity accounts for leptin effect on hepatic but not peripheral insulin action. Am J Physiol Endocrinol Metab 1999;277:E291-E298.
129. Bjorntorp P, Gustafson A, Persson B. Adipose tissue fat cell size and number in relation to metabolism in endogenous hypertriglyceridemia. Acta Med Scand 1971;190:363-367.
130. Bjorntorp P, Bengtsson C, Blohme G, et al. Adipose tissue fat cell size and number in relation to metabolism in randomly selected middle-aged men and women. Metabolism 1971;20:927-935.
131. Reynisdottir S, Dauzats M, Thorne A, et al. Comparison of hormone-sensitive lipase activity in visceral and subcutaneous human adipose tissue. . Clin Endocrinol Metab 1977;82:4162-4166.
132. Masuzaki H, Paterson J, Shinyama H, et al: A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-2170.
133. Rask E, Olsson T, Soderberg S, et al: Tissue-specific dysregulation of cortisol metabolism in human obesity. . Clin Endocrinol Metab 2001;86:1418-1421.
134. Kelley DE, Thaete FL, Troost F, et al: Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000;278:E941-E948.
135. Misra A, Garg A, Abate N, et al: Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. Obes Res 1997;5:93-99.
136. Kissebah AH, Alfarsi S, Adams PW, et al: Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia 1976;2:563-571.
137. Lewis GF, Uffelman KD, Szeto LW, et al. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. . Clin Invest 1995;95:158-166.
138. Ginsberg HN. Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels. Diabetes 1996;45 [Suppl 3]:S27-S30.
139. Cummings MH, Watts GF, Umpleby AM, et al. Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetes 1995;44:1059-1065.
140. Rossetti L, Hawkins M, Shamoon H, et al. Scientific Sessions of the 60th Annual Meeting of the American Diabetes Association, San Antonio, TX, June 2000 (abst).